 | • レポートコード：GIR201102674 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、市中感染型MRSA(CA-MRSA) 治療薬の世界市場を調査対象にし、市中感染型MRSA(CA-MRSA) 治療薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（VAL-301、GLPG-1492、ソリスロマイシン、塩酸アコラフロキサシン、その他）、用途別分析（病院、クリニック、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Allergan Plc、Syntiron LLC、Galapagos NV、Merck & Co Inc、Valevia UK Ltd ・メーカー別販売量、売上、市場シェア ・市中感染型MRSA(CA-MRSA) 治療薬の地域別市場分析 ・市中感染型MRSA(CA-MRSA) 治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・市中感染型MRSA(CA-MRSA) 治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・市中感染型MRSA(CA-MRSA) 治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・市中感染型MRSA(CA-MRSA) 治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・市中感染型MRSA(CA-MRSA) 治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・市中感染型MRSA(CA-MRSA) 治療薬の種類別市場規模2015-2020：VAL-301、GLPG-1492、ソリスロマイシン、塩酸アコラフロキサシン、その他 ・市中感染型MRSA(CA-MRSA) 治療薬の用途別市場規模2015-2020：病院、クリニック、その他 ・市中感染型MRSA(CA-MRSA) 治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug market has been segmented into
VAL-301
GLPG-1492
Solithromycin
Acorafloxacin Hydrochloride
Others
By Application, Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug market.
The report offers in-depth assessment of the growth and other aspects of the Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Share Analysis
Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug sales, revenue and market share for each player covered in this report.
The major players covered in Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug are:
Allergan Plc
Syntiron LLC
Galapagos NV
Merck & Co Inc
Valevia UK Ltd
Among other players domestic and global, Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug, with price, sales, revenue and global market share of Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug in 2018 and 2019.
Chapter 3, the Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 VAL-301
1.2.3 GLPG-1492
1.2.4 Solithromycin
1.2.5 Acorafloxacin Hydrochloride
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Overview of Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market
1.4.1 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Allergan Plc
2.1.1 Allergan Plc Details
2.1.2 Allergan Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Allergan Plc SWOT Analysis
2.1.4 Allergan Plc Product and Services
2.1.5 Allergan Plc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Syntiron LLC
2.2.1 Syntiron LLC Details
2.2.2 Syntiron LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Syntiron LLC SWOT Analysis
2.2.4 Syntiron LLC Product and Services
2.2.5 Syntiron LLC Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Galapagos NV
2.3.1 Galapagos NV Details
2.3.2 Galapagos NV Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Galapagos NV SWOT Analysis
2.3.4 Galapagos NV Product and Services
2.3.5 Galapagos NV Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck & Co Inc
2.4.1 Merck & Co Inc Details
2.4.2 Merck & Co Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck & Co Inc SWOT Analysis
2.4.4 Merck & Co Inc Product and Services
2.4.5 Merck & Co Inc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Valevia UK Ltd
2.5.1 Valevia UK Ltd Details
2.5.2 Valevia UK Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Valevia UK Ltd SWOT Analysis
2.5.4 Valevia UK Ltd Product and Services
2.5.5 Valevia UK Ltd Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
4.3 Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
4.5 South America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales, Revenue and Market Share by Country
5.1.1 North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
5.3 Canada Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
6.3 UK Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
6.4 France Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
6.5 Russia Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
6.6 Italy Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
7.3 Japan Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
7.4 Korea Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
7.5 India Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
7.7 Australia Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales, Revenue and Market Share by Country
8.1.1 South America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Market Share by Type (2015-2020)
10.2 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Price by Type (2015-2020)
11 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Segment by Application
11.1 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Market Share by Application (2015-2020)
11.2 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Market Share by Application (2015-2020)
11.3 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Forecast (2021-2025)
12.2.2 Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Forecast (2021-2025)
12.2.4 South America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Forecast (2021-2025)
12.3 Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Forecast by Type (2021-2025)
12.3.1 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Share Forecast by Type (2021-2025)
12.4 Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Forecast by Application (2021-2025)
12.4.1 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Allergan Plc Basic Information, Manufacturing Base and Competitors
Table 8. Allergan Plc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Major Business
Table 9. Allergan Plc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Total Revenue (USD Million) (2018-2019)
Table 10. Allergan Plc SWOT Analysis
Table 11. Allergan Plc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Product and Services
Table 12. Allergan Plc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Syntiron LLC Basic Information, Manufacturing Base and Competitors
Table 14. Syntiron LLC Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Major Business
Table 15. Syntiron LLC Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Total Revenue (USD Million) (2018-2019)
Table 16. Syntiron LLC SWOT Analysis
Table 17. Syntiron LLC Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Product and Services
Table 18. Syntiron LLC Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Galapagos NV Basic Information, Manufacturing Base and Competitors
Table 20. Galapagos NV Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Major Business
Table 21. Galapagos NV Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Total Revenue (USD Million) (2018-2019)
Table 22. Galapagos NV SWOT Analysis
Table 23. Galapagos NV Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Product and Services
Table 24. Galapagos NV Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Merck & Co Inc Basic Information, Manufacturing Base and Competitors
Table 26. Merck & Co Inc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Major Business
Table 27. Merck & Co Inc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Total Revenue (USD Million) (2018-2019)
Table 28. Merck & Co Inc SWOT Analysis
Table 29. Merck & Co Inc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Product and Services
Table 30. Merck & Co Inc Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Valevia UK Ltd Basic Information, Manufacturing Base and Competitors
Table 32. Valevia UK Ltd Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Major Business
Table 33. Valevia UK Ltd Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Total Revenue (USD Million) (2018-2019)
Table 34. Valevia UK Ltd SWOT Analysis
Table 35. Valevia UK Ltd Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Product and Services
Table 36. Valevia UK Ltd Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales by Manufacturer (2018-2019) (K Pcs)
Table 38. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales by Regions (2015-2020) (K Pcs)
Table 40. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Market Share by Regions (2015-2020)
Table 41. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales by Countries (2015-2020) (K Pcs)
Table 43. North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Market Share by Countries (2015-2020)
Table 44. North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Market Share by Countries (2015-2020)
Table 46. Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales by Countries (2015-2020) (K Pcs)
Table 47. Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Market Share by Countries (2015-2020)
Table 48. Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales by Regions (2015-2020) (K Pcs)
Table 50. Asia-Pacific Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales by Countries (2015-2020) (K Pcs)
Table 53. South America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Market Share by Countries (2015-2020)
Table 54. South America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales by Countries (2015-2020) (K Pcs)
Table 57. Middle East & Africa Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Market Share by Countries (2015-2020)
Table 60. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Share by Type (2015-2020)
Table 62. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue by Type (2015-2020) (USD Million)
Table 63. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Share by Type (2015-2020)
Table 64. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales by Application (2015-2020) (K Pcs)
Table 65. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Share by Application (2015-2020)
Table 66. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Forecast by Regions (2021-2025) (K Pcs)
Table 67. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Share Forecast by Regions (2021-2025)
Table 68. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Forecast by Type (2021-2025) (K Pcs)
Table 69. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Share Forecast by Type (2021-2025)
Table 70. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Forecast by Application (2021-2025)
Table 71. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Picture
Figure 2. Global Sales Market Share of Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug by Type in 2019
Figure 3. VAL-301 Picture
Figure 4. GLPG-1492 Picture
Figure 5. Solithromycin Picture
Figure 6. Acorafloxacin Hydrochloride Picture
Figure 7. Others Picture
Figure 8. Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Market Share by Application in 2018
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Others Picture
Figure 12. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Market Share by Manufacturer in 2019
Figure 33. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Market Share by Regions (2015-2020)
Figure 40. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Market Share by Regions in 2018
Figure 41. North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
Figure 42. Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
Figure 44. South America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020)
Figure 46. North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Market Share by Countries (2015-2020)
Figure 48. North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Market Share by Countries in 2018
Figure 49. North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Market Share by Countries in 2018
Figure 51. United States Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Market Share by Countries in 2019
Figure 57. Germany Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Market Share by Regions 2019
Figure 65. China Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Market Share by Countries in 2019
Figure 72. South America Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Market Share by Countries in 2019
Figure 73. Brazil Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
後天性感染症検査の世界市場 2020年 Market Overview The global Acquired Infections Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Acquired Infectio…- 院内感染制御感染症の世界市場 2020年 Market Overview The global Healthcare-Acquired Infection market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Healthcare-Acqu…
- 院内感染診断の世界市場 2020年 Market Overview The global Hospital-acquired Infection Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hospi…
- レジスタントスターチの世界市場 2020年 Market Overview The Resistant Starch market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 耐性マルトデキストリンの世界市場 2020年 Market Overview The Resistant Maltodextrin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…